Compare MYNZ & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYNZ | FTFT |
|---|---|---|
| Founded | 2021 | N/A |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 22.0M |
| IPO Year | 2021 | N/A |
| Metric | MYNZ | FTFT |
|---|---|---|
| Price | $1.19 | $0.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 201.8K | 44.5K |
| Earning Date | 12-29-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $659,935.00 | ★ $2,665,719.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.92 | $0.73 |
| 52 Week High | $8.20 | $5.00 |
| Indicator | MYNZ | FTFT |
|---|---|---|
| Relative Strength Index (RSI) | 50.59 | 25.18 |
| Support Level | $1.09 | $0.88 |
| Resistance Level | $1.35 | $0.96 |
| Average True Range (ATR) | 0.11 | 0.08 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 52.11 | 1.37 |
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.